These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type. Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 study. Besic N; Auersperg M; Gazic B; Dremelj M; Zagar I Thyroid; 2012 Feb; 22(2):131-7. PubMed ID: 22175241 [TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of highly malignant thyroid tumors]. Kober F; Heiss A; Keminger K; Depisch D Wien Klin Wochenschr; 1990 Apr; 102(9):274-6. PubMed ID: 2165340 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study. Scherübl H; Raue F; Ziegler R J Cancer Res Clin Oncol; 1990; 116(1):21-3. PubMed ID: 2312602 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy and multimodality treatment in thyroid carcinoma. Ekman ET; Lundell G; Tennvall J; Wallin G Otolaryngol Clin North Am; 1990 Jun; 23(3):523-7. PubMed ID: 1694985 [TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy for medullary cancer of the thyroid. Phase II trials with adriamycin and cis-platinum administered as monochemotherapy]. Droz JP; Rougier P; Goddefroy V; Schlumberger M; Gardet P; Parmentier C Bull Cancer; 1984; 71(3):195-9. PubMed ID: 6541515 [TBL] [Abstract][Full Text] [Related]
10. [Combination therapy with adriamycin, cisplatin and vindesine in C cell carcinoma of the thyroid]. Scherübl H; Raue F; Ziegler R Onkologie; 1990 Jun; 13(3):198-202. PubMed ID: 2204006 [TBL] [Abstract][Full Text] [Related]
11. Preoperative chemotherapy for giant cell carcinoma of the thyroid. Spanos GA; WolK D; Desner MR; Khan A; Platt N; Khafif RA; Cortes EP Cancer; 1982 Dec; 50(11):2252-6. PubMed ID: 6182970 [TBL] [Abstract][Full Text] [Related]
12. A phase II trial of streptozotocin and adriamycin in advanced APUD tumors. Frame J; Kelsen D; Kemeny N; Cheng E; Niedzwiecki D; Heelan R; Lippermann R Am J Clin Oncol; 1988 Aug; 11(4):490-5. PubMed ID: 2841843 [TBL] [Abstract][Full Text] [Related]
14. Response of medullary thyroid carcinomas and carcinoid tumors to adriamycin. Ravry MJ Cancer Treat Rep; 1977; 61(1):106-7. PubMed ID: 861958 [No Abstract] [Full Text] [Related]
15. Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients. Gottlieb JA; Hill CS N Engl J Med; 1974 Jan; 290(4):193-7. PubMed ID: 4808917 [No Abstract] [Full Text] [Related]
16. Failure of medullary carcinoma of the thyroid to respond to doxorubicin therapy. Husain M; Alsever RN; Lock JP; George WF; Katz FH Horm Res; 1978; 9(1):22-5. PubMed ID: 618781 [TBL] [Abstract][Full Text] [Related]
17. [Results of chemotherapy in thyroid cancer]. Benker G; Reinwein D Dtsch Med Wochenschr; 1983 Mar; 108(11):403-6. PubMed ID: 6186447 [TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and therapy of undifferentiated thyroid neoplasms; chemotherapy]. Tsutsui K Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1196-201. PubMed ID: 9379099 [No Abstract] [Full Text] [Related]
20. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas. Sulkes A; Uziely B; Isacson R; Brufman G; Biran S Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]